What You Should Know:
– Salesforce (NYSE: CRM), the world’s #1 CRM, today announced that AstraZeneca (LSE/STO/Nasdaq: AZN), a global, science-led biopharmaceutical company, has selected Agentforce Life Sciences for Customer Engagement to help transform its customer engagement…
Continue Reading
What You Should Know:
– Pfizer Inc. has announced a historic agreement with the Trump Administration that is designed to ensure U.S. patients pay lower prices for their prescription medicines while strengthening America’s role as…
Continue Reading
Matthew Weaver, VP, Global Industry – Life Sciences, Rockwell Automation
Biopharmaceutical companies today are facing a very different manufacturing challenge than they were a decade ago. Traditional production models were built to make large volumes…
Continue Reading
What You Should Know:
– Pfizer Inc. and Metsera, Inc. have entered into a definitive agreement under which Pfizer will acquire Metsera, a clinical-stage biopharmaceutical company focused on developing medicines for obesity and cardiometabolic diseases…
Continue Reading
What You Should Know:
– Nicoya Lifesciences, Inc., a leading provider of advanced biologics characterization tools for drug discovery and development, today announced its acquisition of Applied Photophysics, a UK-based provider of biophysical characterization instrumentation.
– Applied Photophysics, bringing…
Continue Reading
AI-backed imaging and care coordination company Viz.ai is partnering with biotechnology company Regeneron and biopharmaceutical company Sanofi to deploy and study an AI-enabled workflow tool for COPD. Viz.ai offers a care coordination platform with more…
Continue Reading
Data sharing technology company Datavant announced it will acquire Aetion, a company focused on real-world evidence in healthcare.Aetion will join Datavant to offer an end-to-end real-world evidence (RWE) platform, allowing healthcare and life sciences…
Continue Reading
What You Should Know:
– The pharmaceutical research and development (R&D) sector is experiencing a significant upswing, with projected returns on investment climbing to 5.9% in 2024, according to a new report by Deloitte.
– This…
Continue Reading
Sai Bhamidipati, Pharmaceutical Regulatory Affairs Consultant
The biopharmaceutical landscape is transforming with the advent of advanced therapeutics, including mRNA vaccines, gene therapies, and personalized medicine. These innovative treatments offer unprecedented opportunities to address complex diseases….
Continue Reading
Cognizant, an IT consulting firm, announced it is expanding its existing relationship with biopharmaceutical company Gilead Sciences to deliver better cost leadership and productivity enhancement for Gilead, while extracting greater value from the existing…
Continue Reading
